Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sangamo Therapeutics (NQ: SGMO )

1.940 -0.210 (-9.77%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,134,789
Open 2.210
Bid (Size) 1.940 (5)
Ask (Size) 1.980 (23)
Prev. Close 2.150
Today's Range 1.930 - 2.210
52wk Range 0.3040 - 3.179
Shares Outstanding 145,337,046
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain
From Sangamo Therapeutics, Inc.
Via Business Wire

Performance

YTD
+248.73%
+248.73%
1 Month
+11.49%
+11.49%
3 Month
+143.05%
+143.05%
6 Month
+231.40%
+231.40%
1 Year
+330.25%
+330.25%

More News

Read More
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
From Sangamo Therapeutics, Inc.
Via Business Wire
Earnings Scheduled For November 12, 2024
Via Benzinga
Sangamo Therapeutics's Earnings Outlook
Via Benzinga
4 Analysts Have This To Say About Sangamo Therapeutics
Via Benzinga
Why Is Sangamo Therapeutics (SGMO) Stock Up 52% Today?
Via InvestorPlace
Zeta Global, Spirit Airlines And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Sangamo Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
From Sangamo Therapeutics, Inc.
Via Business Wire
Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Peering Into Sangamo Therapeutics's Recent Short Interest
Via Benzinga
Nasdaq Turns Higher; Verizon Shares Fall After Q3 Results
Via Benzinga
What's Going On With Sangamo Therapeutics Shares Tuesday?
Via Benzinga
Exposures Product Safety
Crude Oil Rises Sharply; 3M Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Falls Over 150 Points; General Motors Tops Q3 Views
Via Benzinga
Topics Stocks
Exposures US Equities
Sangamo Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in Fabry Disease With BLA Submission Expected in 2025
From Sangamo Therapeutics, Inc.
Via Business Wire
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
Via Benzinga
Exposures Product Safety
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial Results
From Sangamo Therapeutics, Inc.
Via Business Wire
Why Sangamo Therapeutics Stock Is Soaring
Via Benzinga
Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases
From Sangamo Therapeutics, Inc.
Via Business Wire
Sangamo Therapeutics Announces Second Quarter 2024 Conference Call and Webcast
From Sangamo Therapeutics, Inc.
Via Business Wire
Why Is Sangamo Therapeutics (SGMO) Stock Up 40% Today?
Via InvestorPlace
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.